glp-1 for addiction Alcohol Cravings: How Ozempic Helps Quit Drinking GLP‑1 drugs may fight addiction

An extended release GLP-1 analogue increases alpha-synuclein accumulation in a mouse model of prodromal Parkinsons disease

A consumer study of 274 participants found that 91% reported reduced food cravings after six weeks and 88% reported reduced sugar cravings

Graefe-Mody et al., Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin*, Diabetes Obes

Your "full" sensation will be much stronger and arrive much faster than before GLP-1s

All interventions were compared with current use of SGLT2is (20% of the total population) and GLP-1 RAs (5% of the total population)

doi: 10.2147/DDDT.S556231, Summary Keywords fibrosis, glucagon-like peptide-1 receptor agonists, inflammation, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease Citation Lu X and Yang L (2026) Glucagon-like peptide-1 and dual/triple receptor agonists in the treatment of metabolic dysfunction-associated steatotic liver disease: advances in mechanistic research